http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#head
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#provenance
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion
http://rdf.disgenet.org/resource/gda/DGNb574db4f46ce00eebe4cda3e50a68b1d
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/1080
http://rdf.disgenet.org/resource/gda/DGNb574db4f46ce00eebe4cda3e50a68b1d
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0010674
http://rdf.disgenet.org/resource/gda/DGNb574db4f46ce00eebe4cda3e50a68b1d
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001122
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#provenance
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion
http://purl.org/dc/terms/description
[The potentiator Kalydeco� (also known as Ivacaftor or VX-770), developed by Vertex Pharmaceuticals, has been recently approved by the US FDA and the European Medicines Agency (EMA) for the treatment of CF patients carrying at least one CFTR allele with the p.Gly551Asp mutation (2-5 % of all patients).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/23757197
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/dc/terms/created
2017-10-17T13:11:32+02:00
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP211215.RARTZAJEOpHlbEgxNo-ca5of-7xKOG-jF953Z-ixMFGSI
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0